Decreased SLC16A13 Expression Level Can Increase Apoptosis in KATO2 Cell Line, A Promising Biomarker.

Samira ZavarpourHabib ZarredarNegar PedramTouraj Asvadi KermaniZahra SoleimaniShahriyar HashemzadehAtefeh AnsarinMortaza Raeisi

Published in: Asian Pacific journal of cancer prevention : APJCP (2024)

The findings indicate that targeting SLC16A13 can effectively increase cell death and apoptosis in gastric cancer cells, making it a viable therapeutic target.

Keyphrases

cell death
cell cycle arrest
endoplasmic reticulum stress
oxidative stress
poor prognosis
pi k akt
cancer therapy
binding protein
signaling pathway